Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bjørkum

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Brain Research Bulletin|January 1, 1996
Sleep/waking effects following intrathecal administration of the 5-HT(1A) Agonist 8-OH-DPAT alone and in combination with the putative 5-HT(1A) antagonist NAN-190 in ratsA A Bjørkum, R Ursin
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 10, 1993
[The words "weak" and "ill" have many synonyms and dialect terms]A Bjørkum, R Bjørkum, P Stavem
Pharmacology, Biochemistry, and Behavior|September 1, 1988
The relative contribution of ascending and descending serotonergic pathways in p-chloroamphetamine-induced antinociceptionA A Bjørkum, O G Berge
Sleep|July 1, 1995
Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combinationB Bjorvatn, A A Bjørkum, D Neckelmann, et al.
Brain Research|September 18, 1995
Sleep effects following intrathecal administration of the 5-HT1A agonist 8-OH-DPAT and the NMDA antagonist AP-5 in ratsA A Bjørkum, B Bjorvatn, D Neckelmann, et al.
Behavioural Brain Research|September 1, 1996
Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administrationD Neckelmann, B Bjorvatn, A A Bjørkum, et al.
Behavioural Brain Research|February 1, 1996
Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopramD Neckelmann, A A Bjørkum, B Bjorvatn, et al.
Physiology & Behavior|May 1, 1995
Lesion of descending 5-HT pathways increases zimeldine-induced waking in ratsA A Bjørkum, D Neckelmann, B Bjorvatn, et al.
Brain Research|April 3, 2001
Sleep and waking following microdialysis perfusion of the selective 5-HT1A receptor antagonist p-MPPI into the dorsal raphe nucleus in the freely moving ratE Sørensen, J Grønli, B Bjorvatn, et al.
Acta Physiologica (Oxford, England)|December 18, 2007
Increased extracellular 5-HT but no change in sleep after perfusion of a 5-HT1A antagonist into the dorsal raphe nucleus of ratsE Fiske, C M Portas, J Grønli, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Brain Research Bulletin|January 1, 1996
Sleep/waking effects following intrathecal administration of the 5-HT(1A) Agonist 8-OH-DPAT alone and in combination with the putative 5-HT(1A) antagonist NAN-190 in ratsA A Bjørkum, R Ursin
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 10, 1993
[The words "weak" and "ill" have many synonyms and dialect terms]A Bjørkum, R Bjørkum, P Stavem
Pharmacology, Biochemistry, and Behavior|September 1, 1988
The relative contribution of ascending and descending serotonergic pathways in p-chloroamphetamine-induced antinociceptionA A Bjørkum, O G Berge
Sleep|July 1, 1995
Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combinationB Bjorvatn, A A Bjørkum, D Neckelmann, et al.
Brain Research|September 18, 1995
Sleep effects following intrathecal administration of the 5-HT1A agonist 8-OH-DPAT and the NMDA antagonist AP-5 in ratsA A Bjørkum, B Bjorvatn, D Neckelmann, et al.
Behavioural Brain Research|September 1, 1996
Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administrationD Neckelmann, B Bjorvatn, A A Bjørkum, et al.
Behavioural Brain Research|February 1, 1996
Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopramD Neckelmann, A A Bjørkum, B Bjorvatn, et al.
Physiology & Behavior|May 1, 1995
Lesion of descending 5-HT pathways increases zimeldine-induced waking in ratsA A Bjørkum, D Neckelmann, B Bjorvatn, et al.
Brain Research|April 3, 2001
Sleep and waking following microdialysis perfusion of the selective 5-HT1A receptor antagonist p-MPPI into the dorsal raphe nucleus in the freely moving ratE Sørensen, J Grønli, B Bjorvatn, et al.
Acta Physiologica (Oxford, England)|December 18, 2007
Increased extracellular 5-HT but no change in sleep after perfusion of a 5-HT1A antagonist into the dorsal raphe nucleus of ratsE Fiske, C M Portas, J Grønli, et al.
Pageof 2